The FDA just held its first public workshop on testosterone for menopausal women, with prescriptions up 146% and no approved product for women. Here's what was said, what the evidence supports, and how to think about it for yourself.
The pill, patch, ring, implant, and hormonal IUD can hide the cycle changes that signal perimenopause. What gets masked, how long you still need contraception, and why AMH tests can't tell you when menopause starts.
Your youngest is two or three and you are still exhausted, foggy, and short-tempered. Postpartum thyroid problems, low iron, sleep debt, and perimenopause overlap. What to check and what the research shows.
Brain fog, missed deadlines, and emotional overwhelm in your late 30s and 40s may be perimenopause, ADHD, or both. What a 2025 population study found, what is still unproven, and how to get a clear answer.
Losing your train of thought mid-meeting, hot flashes on camera, and sleep that doesn't recover. What the research shows about perimenopause and work, and practical steps that help without disclosing anything.
Sleep scores, skin temperature, and heart rate variability can show patterns in perimenopause, but no wearable can diagnose it. What the data can and can't tell you, and how to use it with your clinician.
Tired, anxious, sleeping badly, and cycles changing in your late 30s or early 40s. It may be perimenopause, but several other conditions look the same. What to rule out, what to test, and when testing is useful.
Your periods arrive on schedule, but sleep, mood, and PMS have changed. Hormones start shifting before cycles become irregular. What the research shows, what to track, and what to ask for.
New anxiety, irritability, or rage in your 40s may be perimenopause, an anxiety disorder, or both. What the SWAN research shows, the clues that separate them, and what treatment actually has evidence.
Burning mouth, ringing ears, frozen shoulder, crawling skin, electric zaps, palpitations, dry eyes. The menopause symptoms that don't make the usual lists, why they happen, and which ones need a closer look.
A burning, scalding, or numb mouth with nothing visibly wrong is one of the least-known menopause symptoms. What the research says about burning mouth syndrome, what to rule out first, and what helps.
Spinning when you roll over in bed, ringing in your ears, a floaty off-balance feeling. How estrogen affects the inner ear, what's well supported and what isn't, and when dizziness needs urgent attention.
Frozen shoulder peaks in women aged 40 to 60, the same window as perimenopause. What the research says about estrogen and joint pain, what else to rule out, and what to do before the shoulder locks up.
Itching with no rash, a feeling of insects crawling under the skin, tingling hands, sudden electric zaps. The skin and nerve symptoms of menopause are real, under-studied, and worth sorting from their look-alikes.
Fluttering, skipped beats, or a racing heart in your forties are common in perimenopause. What the research shows, what to get checked so you know it's hormonal, and which symptoms mean go now.
Gritty, burning, blurry eyes are common around menopause, and the hormone story is more complicated than low estrogen. What the research shows, what to rule out, and what actually helps.
Two oral GLP-1s are now on the market and a third generation is coming. Here's how the pills compare to the injections on weight loss, convenience, cost, and the muscle-and-bone question that matters most after forty.
Up to 40% of what you lose on a GLP-1 can be lean tissue. In midlife that's muscle and bone you won't easily get back. The protocol I build around every GLP-1 prescription — and what the new muscle-preserving drugs actually showed.
The most common reason a good hormone protocol fails isn't the protocol. It's a stress response that never gets to stand down. Why nervous-system regulation has become the first step in functional medicine — and what it looks like in practice.
Rosacea at 45, acne along the jaw, skin that looks tired no matter the serum. The gut–skin axis is real, it's bidirectional, and in midlife it's tangled up with your hormones. What the research shows and where to look first.
Years of high output on a stress system that never got to reset. Here's the physiology behind the Bossy Betty archetype — the cortisol crash — and where recovery actually starts.
Her cortisol total may be normal — but the daily rhythm is running upside down. The Wired Wendy archetype explained: the inverted curve, the 10 PM second wind, and how to flip it back.
Weight-loss resistance, cold hands, brain fog, and a TSH someone called normal. The Plateau Patty archetype is thyroid and metabolic slowdown — and the gap between normal and optimal is where she lives.
Heavy periods, breast tenderness, mood swings that track the calendar. The Moody Maven archetype is estrogen dominance — and it's usually a clearance problem, not a production problem.
Hot flashes, 3 AM waking, cycles that don't behave, moods that feel borrowed. The Hot Mama archetype is perimenopause onset — estrogen swinging while progesterone falls — and here's how to steady it.
Bloating that builds through the day, food reactions, irregularity — and hormone symptoms riding along. The Bloated Brenda archetype is the gut-hormone axis, where estrogen is meant to leave the body and doesn't.
Afternoon crashes, cravings, weight at the waist, and a fasting glucose someone called fine. The Sugar Sherry archetype is insulin resistance — the cells have stopped hearing the signal — and it's reversible.
A year past your last period and still exhausted, foggy, dry, achy, and losing muscle. The Depleted Debbie archetype is post-menopause depletion — the steady state after the swings — and it's the one women are told to simply accept.
New anxiety, a racing mind at night, PMS that turned into dread, a cycle that's shortening. The Anxious Annie archetype is low progesterone — and the calming brain chemistry that went with it.
Menopause is one day. Everything else has a different name, a different hormonal signature, and a different set of things worth doing. Here is the whole arc, laid out.
An FDA advisory panel voted against its own agency scientists and recommended six peptides for compounding. It was genuinely remarkable. It also changed nothing about what is legal today, and that gap is where people are getting confused.
A woman with no history of anxiety develops it at 44 and is told she is stressed. There is a receptor-level explanation, and it deserves to be part of the conversation before a prescription is.
Two women with identical symptoms can need opposite things. That is why generic hormone advice fails so reliably — and why I started sorting patterns instead.
You're eating well, exercising consistently, and still the scale won't budge. Before you blame willpower, consider the hormonal drivers of weight loss resistance most doctors never test.
One acts on a single receptor, the other on two. The head-to-head trial produced a clear winner on weight — and a finding about women specifically that most coverage skipped entirely.
Hot flashes and irregular cycles get all the attention — but perimenopause can begin years earlier with symptoms most women (and their doctors) never connect to hormones. Here's what to watch for and when to act.
Unlike almost everything else on this menu, this one has a genuine FDA approval for a women's health condition. The catch is which women the approval covers — and it may not be the ones asking.
Fatigue, weight gain, hair loss, cold intolerance, brain fog — these symptoms point to both thyroid dysfunction and hormonal imbalance. Conventional medicine often tests one and misses the other. Functional medicine tests both — and looks at how they interact.
It is the one growth hormone peptide that was once an approved drug. That history is the most interesting thing about it, and the most useful context for deciding whether it belongs in your plan.
Most longevity peptides have thin human evidence. This one is different — it has been through real clinical trials under the name elamipretide. Here is what that research actually studied, and what it did not.
Standard lab ranges answer a different question than the one you're asking. Here's what 'normal' actually means and which markers deserve a closer look.
Brain fog and anxiety that arrive in your forties are not a personality change. They have a physiology, and it is usually hormonal — which is where any conversation about nootropic peptides has to start.
This is the one compound on the peptide menu where the topical version has better human evidence than the injection. That is worth knowing before you choose.
Most peptides in this category are investigational. This one is an approved drug — though not for the reason most people are asking about it. The distinction is worth understanding.
Joint pain that arrived out of nowhere. Workouts you can't bounce back from. Here's what the research actually shows about the two peptides behind the "Wolverine" protocol — and the hormonal context most articles leave out.
Your thymus starts shrinking in adolescence and is largely fatty tissue by midlife. This peptide comes from what that gland used to produce — and the autoimmune caution matters more than most articles admit.
The most dramatic skin changes of a woman's life aren't a skincare failure — they're an estrogen story. Where the copper peptide GHK-Cu fits, and what it can't fix on its own.
It is one of the few peptides your own mitochondria produce. Researchers have called it an exercise mimetic — a description worth unpacking carefully, because it is both the most interesting and most misused thing said about it.
Some women come in with a gut problem. Some with a skin problem. A surprising number have both — and no one has connected the two for them. The gut–skin axis, explained.
It is genuinely one of the most important molecules your body makes. That is exactly why the marketing around injecting it deserves a careful, skeptical read.
The medication works. The question no one asks loudly enough is what you lose alongside the fat — and in midlife, that question has a much sharper answer than it does at thirty.
It is marketed as the closest thing to a telomere drug. The research base is real but narrow, and mostly published in one country over several decades. Here is what that actually means for a woman considering it.
It hits two receptors instead of one, and the head-to-head trial found women responded even more strongly than men. That difference is worth understanding — along with a contraception interaction most women are never told about.